Saskatchewan Health Concerns, Knee Pain Therapy, and Alzheimer's Drug Approval
Update: 2025-10-30
Description
In this episode, Dr. Chi-Ming Chow welcomes listeners and introduces the day's topics, which cover a range of significant healthcare issues. He begins by discussing concerns raised by healthcare workers in Saskatchewan, focusing on software issues impacting their work. The conversation then shifts to a study on the effectiveness of physical therapy for knee pain, highlighting its potential benefits. Dr. Chow examines the FDA's initiative to make biotech drugs more affordable, shedding light on its implications for patients. He also delves into the controversy surrounding Quebec's doctor remuneration system. The episode concludes with the approval of the Alzheimer's drug lecanemab by Health Canada, exploring its potential impact on treatment options.
(0:00 ) Welcome and introduction
(0:29 ) Saskatchewan health-care workers' concerns and software issues
(7:09 ) Physical therapy for knee pain study
(10:29 ) FDA initiative for affordable biotech drugs
(13:08 ) Quebec doctor remuneration system controversy
(16:49 ) Health Canada approves Alzheimer's drug lecanemab
(0:00 ) Welcome and introduction
(0:29 ) Saskatchewan health-care workers' concerns and software issues
(7:09 ) Physical therapy for knee pain study
(10:29 ) FDA initiative for affordable biotech drugs
(13:08 ) Quebec doctor remuneration system controversy
(16:49 ) Health Canada approves Alzheimer's drug lecanemab
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
